A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 12 July 2024) has been published and includes articles on: Epimax Ointment and Epimax Paraffin-Free Ointment: reports of ocular surface toxicity and ocular chemical injury Letters and medicine recalls sent to healthcare professionals in June 2024. To see the latest [...]
The post MHRA Drug Safety Update: July 2024 appeared first on Community Pharmacy England.
Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (19/07/2024) announced the following initial list of price concessions for July 2024: Drug Pack size Price concession Amantadine 100mg capsules 56 £13.21 Amiloride 5mg tablets 28 £15.20 Benzydamine 0.15% [...]
The post July 2024 Price Concessions 1st Update appeared first on Community Pharmacy England.
Community Pharmacy England reconsidered the immediate priorities for the new Government, alongside wider strategic planning, when members met in Birmingham last month. During a meeting on 26th and 27th June 2024, Committee Members remained focused on the urgent challenges facing pharmacy owners as well as the ongoing work to build a better future for the [...]
The post Approach with new Government and strategic planning considered at June Committee Meeting appeared first on Community Pharmacy England.
We have issued the following statement in response to the disruption affecting various IT systems worldwide, including EMIS and the electronic prescription service systems used by NHS community pharmacies and GP practices in England. Our Director of NHS Services, Alastair Buxton, said: “NHS England has issued a communication to highlight that the global IT issue, [...]
The post Our response to global IT issues affecting various NHS systems, including pharmacies and GPs appeared first on Community Pharmacy England.
The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Clarithromycin 125mg/5ml and 250mg/5ml oral suspensions are now available to meet normal demand. As a result the Serious Shortage Protocols (SSPs), SSP053 for Clarithromycin 125mg/5ml oral suspension and SSP054 for Clarithromycin 250mg/5ml oral suspension expire at 23.59pm on Friday 19 July 2024. [...]
The post Expiry of two Clarithromycin SSPs (SSP053 and SSP054) appeared first on Community Pharmacy England.
Recent Comments